Searchable abstracts of presentations at key conferences in endocrinology

ea0056p298 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease

Naumenka Alena , Adzeriho Igar

Objective: The prevalence of silent myocardial ischemia (SMI) is more frequent in diabetic patients and is associated with a worse prognosis. It has been known that diabetes is a major cardiovascular risk factor; it often leads to severe cardiovascular complications, and coronary artery disease (CAD) is the main cause of death in diabetic patients. The aim was to examine the prevalence and duration of SMI in type 2 diabetes (DT2) patients with ischemic heart disease (IHD)....